2024. UTILIZATION OF DIAGNOSTIC EFFICACY OF Α-METHYLACYL COA RACEMASE (AMACR) AND P63 IN DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA. Journal of Biomedical Investigation. 12, 1 (May 2024), 103–114.